HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Jeffrey Weitz Selected Research
Jeffrey Weitz Research Topics
Disease
5
Hemorrhage
02/2022 - 07/2002
3
Stroke (Strokes)
06/2018 - 09/2002
2
Embolic Stroke
06/2018 - 09/2016
2
Embolism (Embolus)
06/2018 - 09/2016
2
Thrombosis (Thrombus)
05/2003 - 07/2002
1
Chronic Kidney Failure (Chronic Renal Failure)
02/2022
1
Venous Thromboembolism
11/2019
1
Neoplasms (Cancer)
11/2019
1
Arthritis (Polyarthritis)
01/2017
1
Brain Infarction
09/2016
1
Glioma (Gliomas)
04/2010
1
Heart Diseases (Heart Disease)
04/2007
Drug/Important Bio-Agent (IBA)
4
Anticoagulants
IBA
11/2019 - 07/2002
2
Rivaroxaban
IBA
06/2018 - 09/2016
2
Aspirin (Acetylsalicylic Acid)
FDA Link
Generic
06/2018 - 09/2016
2
Factor Xa (Coagulation Factor Xa)
IBA
06/2018 - 09/2016
1
Factor XI (Plasma Thromboplastin Antecedent)
IBA
02/2022
1
edoxaban
IBA
11/2019
1
Dalteparin (Dalteparin Sodium)
FDA Link
11/2019
1
Naproxen (Naprosyn)
FDA Link
Generic
01/2017
1
Celecoxib (Celebrex)
FDA Link
01/2017
1
Biomarkers (Surrogate Marker)
IBA
09/2016
1
Factor Xa Inhibitors
IBA
09/2016
1
ErbB Receptors (EGF Receptor)
IBA
04/2010
1
Factor VII (Proconvertin)
IBA
04/2010
1
Ligands
IBA
04/2010
1
Proteinase-Activated Receptors
IBA
04/2010
1
epidermal growth factor receptor VIII
IBA
04/2010
1
Warfarin (Coumadin)
FDA Link
Generic
09/2002
1
Thrombin
FDA Link
07/2002
1
Heparinoids (Heparinoid)
IBA
07/2002
1
Antithrombins
IBA
07/2002
1
Heparin Cofactor II
IBA
07/2002
1
Heparin (Liquaemin)
FDA Link
Generic
07/2002
Therapy/Procedure
1
Renal Dialysis (Hemodialysis)
02/2022
1
Therapeutics
11/2019
1
Secondary Prevention
09/2016
1
Stroke Rehabilitation
09/2002